...
首页> 外文期刊>Annals of surgical oncology >Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging
【24h】

Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging

机译:基于术前放化疗的晚期低位直肠癌患者术前放化疗选择性盆腔外侧淋巴结清扫术

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: The significance of lateral pelvic lymph node (LPLN) metastasis in advanced low rectal cancer treated with preoperative chemoradiotherapy (CRT) remains unclear. The objective of this study was to evaluate the outcomes of selective LPLN dissection (LPLD) based on the pretreatment imaging in patients with advanced low rectal cancer treated with preoperative CRT. Methods: We reviewed 127 consecutive patients with clinical stage II-III low rectal cancer below the peritoneal reflection who underwent preoperative CRT and curative resection. LPLD was performed in patients with suspected LPLN metastasis based on MDCT or MRI before CRT (LPLD group, N = 38), and only total mesorectal excision (TME) was performed in patients without suspected LPLN metastasis (TME group, N = 89). Clinical characteristics and the oncological outcome were compared between groups. Results: The median tumor-to-anal verge distance was 40 mm in both groups. The median maximum long-axis LPLN diameter before CRT was 0 mm in the TME group and 10.5 mm in the LPLD group. Pathological LPLN metastasis was confirmed in 25 patients (66 %) in the LPLD group. Local recurrence at LPLN developed in 3 patients (3.4 %) in the TME group and in none (0 %) of the LPLD group. Multivariate analysis showed that only ypN was an independent prognostic factor for relapse-free survival (RFS), but LPLN metastasis was not associated with poor RFS. Conclusions: The incidence of LPLN metastasis is high even after preoperative CRT, and LPLD might improve local control and survival of patients with LPLN metastasis in advanced low rectal cancer treated with preoperative CRT.
机译:背景:术前放化疗(CRT)治疗的晚期低位直肠癌的盆腔外侧淋巴结转移(LPLN)的意义尚不清楚。这项研究的目的是根据术前CRT治疗的晚期低位直肠癌患者的术前影像学评估选择性LPLN剥离术(LPLD)的结果。方法:我们回顾了接受腹膜反射以下的临床II-III期低位直肠癌的127例连续患者,这些患者接受了术前CRT和根治性切除。在CRT前根据MDCT或MRI对怀疑有LPLN转移的患者进行LPLD(LPLD组,N = 38),而对没有LPLN转移的患者仅进行全直肠系膜切除(TME)(TME组,N = 89)。比较各组的临床特征和肿瘤学结果。结果:两组肿瘤到肛门的中位距离为40 mm。在CRT之前,TME组的中位最大长轴LPLN直径为0 mm,LPLD组的中位最大长轴LPLN直径为10.5 mm。 LPLD组中25例(66%)患者确认了病理性LPLN转移。 TME组中3例(3.4%)患者出现LPLN局部复发,而LPLD组中无3例(0%)患者复发。多变量分析表明,只有ypN是无复发生存(RFS)的独立预后因素,但LPLN转移与不良RFS无关。结论:即使术前CRT,LPLN转移的发生率仍然很高,而LPLD可以改善术前CRT治疗的晚期低位直肠癌LPLN转移患者的局部控制和生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号